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Abstract
Background:  To validate a questionnaire to assess the activity impairment associated with
uncomplicated urinary tract infection (uUTI).
Methods: The Activity Impairment Assessment (AIA) assesses the amount of time an individual's
work or regular activities have been impaired as a result of their UTI. The measure was completed
by 276 women with uUTI who had participated in a prospective, open-label, non-comparative
multi-centre clinical trial of CIPRO® XR (extended-release ciprofloxacin). Baseline scores on the
King's Health Questionnaire (KHQ) and clinical symptom evaluations were collected for validation
purposes.
Results: An exploratory factor analysis showed that all items loaded >0.84 on a single component.
This uni-dimensional structure was supported by Rasch analysis. The AIA was found to have
excellent levels of internal consistency (Cronbach's alpha = 0.93), convergent validity (all rs >.70)
and divergent validity (rs = .078). The AIA displayed excellent discriminant validity in relation to
clinical evaluations, and was found to be responsive to change across all clinical evaluations.
Conclusion: The unidimensional AIA shows high levels of internal reliability, convergent and
divergent validity, discriminant validity and responsiveness. It is an excellent tool for measuring
activity impairment in UTI.
Background
Urinary tract infections (UTIs) are one of the most com-
mon conditions seen by general practitioners, represent-
ing a significant healthcare cost burden [1]. In the USA
alone there are an estimated seven million physician visits
and one million emergency department visits each year
specifically for UTIs [2,3]. Although it has been reported
that half of all women experience at least one UTI in their
lifetime [2,3], the incidence of UTI is difficult to assess
accurately because UTI is not well reported.
UTIs may be either 'uncomplicated' or 'complicated'.
Complicated UTIs are associated with metabolic, func-
tional, or anatomic abnormalities. An acute
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uncomplicated UTI (uUTI) (also referred to as cystitis,
acute cystitis, and dysuria-frequency syndrome) has been
defined in a number of ways. In women, it includes a clin-
ical syndrome characterised by various combinations of
dysuria (painful urination), frequency, urgency, gross
haematuria, lower back and/or abdominal/suprapubic
discomfort with pyuria and bacteriuria [4,5]. As many as
half of all patients with uUTI may not have bacteriuria
according to established criteria, and have no known
underlying renal or urologic dysfunction or obstruction
[6].
While uUTI is generally considered a benign condition, it
is associated with significant short-term morbidity. The
nature and extent of these limitations has led to this
benign classification being questioned [7]. Malterud and
Baerheim [8] recently demonstrated a wide range of dif-
ferent symptoms in patients with uUTI. The authors con-
cluded that traditional medical knowledge about
symptom presentation in uUTI is insufficient, and that
awareness of symptom diversity and highly individual
presentation may lead to better recognition of the atypical
patient, and to improved diagnosis, treatment, and care
[9].
While there has been some research on the impact of uUTI
on everyday activities, little is known about the impact of
UTI on everyday routine. Foxman and Frerichs [10]
reported that each episode of UTI results in an average of
6.1 symptomatic days and 2.4 restricted-activity days, as
well as time lost from work. In a recent Canadian survey
[11], almost half (48%) of Canadian women who had
experienced a UTI reported that it affected at least one of
their daily activities. Additionally, Decima Research Incor-
porated (2002) reported on the modification of the Wil-
liamson Functional Impairment Scale to measure
outcomes of impairment due to UTI, such as time lost
from usual daily activities.
The Activity Impairment Assessment (AIA) was developed
for the purposes of the present study by the authors in
2003 and was based on an existing work productivity
measure (the Stanford Presenteeism Scale (SPS-6) [12] to
evaluate the impact of health problems on individual per-
formance and productivity. For the AIA measure, the con-
cept of work was broadened to include other activities and
social activities. The AIA includes 5 items, the content of
which can be seen in table 1. The present study was
designed to validate the AIA in the assessment of activity
impairment associated with uUTI.
The data for the validation study came from a clinical trial
of the effectiveness of CIPRO® XR (extended-release cipro-
floxacin) in the treatment of uUTI. The trial was designed
to assess time to improvement of symptoms, the size of
any improvements, and the extent to which women can
resume their daily activities following treatment. The psy-
chometric properties of the AIA were assessed primarily by
the pattern of associations between AIA scores and scores
on the validated King's Health Questionnaire (KHQ). The
assessed properties included internal consistency, conver-
gent and divergent reliability, discriminant validity, and
responsiveness.
Methods
Assessment of reliability and validity
Reliability and validity assessment was conducted in the
context of a 3-day prospective, open-label, non-compara-
tive, multi-centre clinical trial of CIPRO® XR 500 mg.
Women with uUTI were recruited for entry to this trial
between June 18th 2003 and January 23rd 2004. At first
visit, prior to receiving the first dose of study medication,
patients gave written informed consent, a urine sample for
dipstick biochemical analysis for nitrites or leukocyte este-
rase, and a clear-catch midstream urine specimen for cul-
ture and sensitivity. Patients provided demographic and
medical history details (age, ethnicity, years of education,
employment status, previous history of uUTI, number of
days since onset of uUTI before seeing physician) and
completed the patient-reported questionnaires.
Patient reported outcomes were recorded in electronic for-
mat using PalmOS™ palm pilots, with information trans-
ferred to a host computer.
Table 1: Distribution of AIA responses to each individual item
AIA items and total score Mean (SD) Median Range
Cut down on time at work 1.52 (1.07) 2 0–4
Accomplished less 1.67 (1.10) 2 0–4
Limited in kind of work 1.44 (1.20) 2 0–4
Difficulty performing work 1.55 (1.20) 2 0–4
Interfered with social activity 1.38 (1.29) 2 0–4
Total score 7.56 (5.22) 2 0–4Health and Quality of Life Outcomes 2005, 3:42 http://www.hqlo.com/content/3/1/42
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Activity Impairment Assessment (AIA)
The AIA is a self-administered 5-item questionnaire
assessing the amount of time, over the previous 24 hours,
that an individual's work or regular activities have been
impaired as a result of their UTI. Patients respond to AIA
items on a 5-point Likert-type scale, with the response
options 'none of the time', 'a little of the time', 'some of
the time', 'most of the time' and 'all of the time', scored 0–
4.
The AIA was administered on day 2, then every 24 hours
until regular daily activities had been unimpaired by UTI
for 24 hours. Administration was stopped after the patient
indicated at two consecutive administrations of the ques-
tionnaire (over at least 24 hours) that she had no activity
impairment. The measure was completed at Test of Cure
(TOC) visit if the UTI symptoms had persisted or if regular
daily activities were impaired.
King's Health Questionnaire (KHQ)
The KHQ is a self-administered questionnaire designed to
assess the impact of urinary incontinence on QoL in
women. The measure contains 21 questions that are
scored in nine domains (general health perception, incon-
tinence impact, role limitations, physical limitations,
social limitations, personal relationships, emotions,
sleep/energy, severity of urinary symptoms) [13].
Weighted summary scores in each domain range from 0 to
100, with higher scores indicating greater impairment.
Part III of the questionnaire is a list of 10 bladder prob-
lems plus an 'other' category. These items are not summed
to form a domain score.
The KHQ was chosen as the primary instrument in the val-
idation of the AIA because it has been validated for use in
the assessment of women with urinary problems [14,15]
and it contains questions on "bladder problems" (i.e., fre-
quency, urgency, bladder pain etc.) and how much these
problems presently affect the subject.
The KHQ was administered at day 1, day 3, when the sub-
ject indicated that the UTI symptoms had resolved (no
symptoms for 24 hours, or over three data capture points,
whichever was longer), and at the TOC visit.
Clinical evaluation involved an assessment of five UTI
symptoms (dysuria, frequency, urgency, suprapubic pain,
gross haematuria) rated 'none', 'mild', 'moderate', or
'severe', and scored 0–3. The clinical evaluations took
place at visit 1, at any premature discontinuation (day 1 to
day 3), and at the TOC visit.
Statistical methods
The data were analysed primarily in SPSS version 12.0
[16]. The Normality of the distributions of the AIA and
KHQ scores was assessed both visually (using the histo-
gram and superimposed Normal curve) and numerically
using the relation between the distribution mean and the
standard deviation and Kolmogorov-Smirnov statistics.
Where data were found to be non-normally distributed,
non-parametric tests were used. Analysis of variance with
post-hoc Tukey tests (or non-parametric Kruskal-Wallis
tests with Bonferroni-corrected post-hoc Mann-Whitney
tests) were used to compare group scores. Associations
between two continuous variables (absolute or change
scores) were assessed using Pearson's r, (or non-paramet-
ric Spearman's rs) correlation coefficients. Missing values
were handled by excluding cases pairwise. Examination of
the dimensionality of the AIA, and the functioning and fit
of individual items, was undertaken, as described below,
by fitting a Rasch unidimensional measurement model in
RUMM2010 [17]. Statistical significance throughout was
taken at the 5% level (P < .05).
AIA factor structure
Exploratory factor analysis using principle components
extraction and varimax rotation was performed on the 5
AIA items to explore the structure of the measure. Factors
were extracted if their eigenvalue was >1. Domain scores
of any resulting factors, or of a total score, were calculated
as a sum of the component item scores.
Item functioning
Because the AIA does not directly assess symptoms, it was
appropriate to explore the performance of the AIA with
the use of item response theory (IRT). IRT allows an
understanding of how people respond to items and how
items measure an underlying dimension [18]. One of the
simplest IRT models is the one-parameter Rasch model.
The Rasch model assumes that the probability of a
respondent giving a 'correct' answer (or responding at a
given level on the scale) to a particular item is a logistic
function of the relative distance between the item location
parameter and the respondent location parameter [19].
The item-trait interaction Χ 2 statistic was used to assess the
fit of the data to the model, and the item-person interac-
tion mean and SD values (where perfect fit is indicated by
a mean of zero and SD of 1.0) to assess the degree of con-
sensus displayed collectively by all items of the instru-
ment across persons located at differing 'ability' (i.e.,
activity impairment). The divergence of each item from
the Rasch model was assessed using the individual item fit
Χ 2 statistic and residual (a residual >3.0 is generally taken
to indicate misfit and <-3.0 that the item fits the model
too closely), with item thresholds used to assessed
whether, as a person's impairment increases, the probabil-
ity of a maximum score on the item increases. The person-
item threshold map was used to assess whether the ques-
tionnaire items represent respondents of all levels of
impairment, and item characteristic curves whether anyHealth and Quality of Life Outcomes 2005, 3:42 http://www.hqlo.com/content/3/1/42
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item significantly over- or under-estimates the impair-
ment level.
Internal consistency reliability
Cronbach's alpha statistics were calculated to assess the
internal consistency reliability of the AIA scores.
Convergent validity
The convergent validity of the AIA was assessed using
Spearman's correlation coefficients between the AIA score
and similar individual symptom and domain scores of the
KHQ. The AIA score was expected to be significantly asso-
ciated with the 'role limitations', 'social limitations', and
'physical limitations' domain scores of the KHQ.
Divergent validity
The divergent validity of the AIA was assessed using Spear-
man's correlation coefficients between the AIA score and
dissimilar individual symptom and domain scores on the
KHQ. Because short-term UTI is not expected to have a
major impact on one's personal relationships, divergent
validity was assessed by calculating the Spearman correla-
tion coefficient between the AIA score and the KHQ 'Per-
sonal Relationships' domain.
Discriminant validity
The discriminant validity of the AIA was assessed by using
Kruskal-Wallis analysis of variance to compare AIA
domain scores (at first administration) between the initial
clinical ratings for dysuria, frequency, urgency, suprapu-
bic pain, and gross haematuria. It was hypothesised that
AIA scores would differ significantly between the clinical
groups.
Responsiveness
It was hypothesised that the change in AIA score from visit
1 to the time when symptoms were no longer present
would be related to improvements in the clinical evalua-
tion of UTI. Change scores for the AIA and clinical evalu-
ations were calculated by subtracting the TOC scores from
the initial scores. Spearman correlation coefficients were
used to assess the degree of association between the meas-
ures of change and Kruskal-Wallis analysis of variance for
comparisons of group mean change scores.
Results
Patient characteristics
Two hundred and seventy six women were recruited to the
study. The mean (SD) age of the women was 33.0 (11.46)
years (range 18–78 years). Although the sample was eth-
nically diverse [12% (n = 34) black, 4% (n = 12) American
Indian, 2% (n = 5) Hispanic], the majority of the women
(70%, n = 193) in the study were white. Thirty-two
women (12%) did not give any details of their ethnic ori-
gin. Five women (1.8%) reported that they had attended
grade school only, while around half of the women
(52.4%, n = 143) completed high school. A further 40.3%
(n = 110) attended college and 15 (5.5%) attended grad-
uate school. In response to the question 'which best
describes what you were doing in the past 6 months',
49.5% (n = 135) reported that they had more than one
role. One hundred and seventy five women (64.5%) were
working full time, 65 (23.8%) were working part time,
while 107 (39.2%) women were looking after the house
and/or children full time. Fifty-three (19.4%) women
were studying at university either full or part time, and 46
(6.8%) reported that they were engaged in some other
role.
The majority of women were considered to have moderate
or severe dysuria (n = 208, 75.4%), frequency (n = 238,
86.2%), and urgency (n = 237, 85.9%) at baseline clinical
evaluation. Suprapubic pain was less common, with the
majority of women (n = 179, 64.9%) rated as having
either mild or moderate subrapubic pain. Haematuria was
reported as absent in 151 women (54.7%).
Factor structure of the AIA
On unforced principal components factor analysis on the
AIA scores at baseline, one component was extracted that
explained 78.6% of the variance in the data (Table 1). The
loadings for each item on the single component were =
0.85. This supported the use of the AIA items as a single
scale (called the AIA total score), scored as the sum of the
5 individual item scores.
Data distribution
Patients used the full range of responses for each AIA item,
with the median response for each item being 2.0 ('some
of the time') (Table 1). The full range of scores was also
used for the overall scale, with scores ranging from 0 (no
limitations) to 20 (maximum level of limitations).
Twenty-six patients (9.4%) reported no limitations at
baseline with the distribution at lower levels of limitation
appearing fairly uniform, but with smaller numbers of
patients reporting extreme degrees of limitation (kurtosis
= -0.98, SE = 0.29). The mean (SD) AIA total score was
7.56 (5.22) with a median of 7.00, also indicating non-
Normality which was confirmed on Kolmogorov-Smir-
nov test (P < .001).
Association of AIA score with demographic variables
There were no statistically significant associations
between AIA scores and respondent age, ethnic group, or
work status.
Item functioning
Because factor analysis showed that the AIA is a uni-
dimensional scale the one-parameter Rasch model was fit-
ted to the data. Although the model fitted the data wellHealth and Quality of Life Outcomes 2005, 3:42 http://www.hqlo.com/content/3/1/42
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(item-trait interaction Χ 2 = 20.32, P = .16), there was some
suggestion of a small amount of misfit of the items and
persons to the model (item-person interaction mean = -
0.64, SD = 1.42). However, in terms of individual item fit,
no Χ 2 statistic reached statistical significance and no resid-
ual was >|3| (Table 2). In addition, all items displayed
ordered thresholds. The person-item threshold distribu-
tion map showed that the item thresholds cover the
majority of respondent 'abilities' (i.e., activity impair-
ment) in the sample. Only four thresholds were posi-
tioned at the same severity level, suggesting that all the
items and response options are valuable in measuring the
full range of activity impairment levels. Finally, the item
characteristic curves demonstrated that the AIA performs
very well across all activity impairment severity levels and
does not significantly overestimate or underestimate any
group's activity level.
Internal consistency
The Cronbach's alpha coefficient for the AIA scale score
was 0.93, confirming the internal consistency of the 5-
item AIA. All items contributed equally to the reliability of
the scale as all 'alpha if item deleted' coefficients were
between 0.90 and 0.92.
Convergent and divergent validity
The convergent validity of the AIA was demonstrated by
high and statistically significant correlations between the
AIA score and the KHQ 'role limitations' (rs = 0.76, P <
.001), 'social limitiations' (rs = 0.71, P < .001), and 'phys-
ical limitations' (rs = 0.73, P < .001) domains. Divergent
validity was demonstrated by a low and non-significant
correlation between the AIA score and the KHQ 'personal
relationships' domain (rs = 0.08, P = .201).
Discriminant validity
The discriminant validity of the AIA was demonstrated by
statistically significant differences in AIA scores between
the clinical evaluations of dysuria, frequency, urgency,
and suprapubic pain (Table 3). In particular, the greater
the clinical severity, the greater the AIA score (P < .001).
No significant difference in AIA score was found between
the clinical evaluations of haematuria.
Responsiveness
The AIA score was responsive to changes in the clinical
evaluation of 'Dysuria' (rs = .28, P < .001), 'Frequency' (rs
= .31, P < .001), 'Urgency' (rs = .31, P < .001), 'Suprapubic
pain' (rs = .27, P < .001), and 'Gross Haematuria' (rs = .16,
P = .008). In terms of mean AIA change by degree of
improvement in clinical evaluation, clear trends were evi-
dent for increase in AIA improvement with increased
degree of clinical evaluation improvement (Table 4).
Discussion
This study has reported on the validation of the Activity
Impairment Assessment (AIA) questionnaire in measur-
ing the activity impairment associated with uncompli-
cated urinary tract infection (uUTI).
Table 2: Individual item fit for the AIA items
AIA Item Residual Score Chi-square P-value
1. Cut down on the amount of time you spent on work or other activities 1.735 6.899 0.075
2. Accomplished less than you would like -1.789 3.356 0.340
3. Were limited in the kind of work or other activities -2.118 3.827 0.281
4. Had difficulty performing work or other activities (for example, it took extra effort) -0.652 0.545 0.909
5. Interfered with your social activities (like visiting friends, relatives, etc.) 2.577 5.696 0.127
Table 3: Discriminant validity of the AIA – mean scores by clinical evaluation of 5 symptoms
Symptom Mean AIA total score by clinical evaluation Χ 2
None Milda Moderateb Severec
Dysuria 3.00 5.97 7.19 10.23*** 22.04***
Frequency 3.71 3.03 7.50*** 9.32** 38.96***
Urgency 3.50 4.37 6.88* 9.68*** 37.39***
Suprapubic pain 6.24 6.39 7.97 10.70** 22.46***
Gross hematuria 6.96 7.49 8.26 9.59 7.07
Mann Whitney U tests used to test differences between clinical evaluations aNone and Mild, bMild and Moderate, CModerate and Severe *p < 0.05, 
**p < 0.01, ***p < 0.001Health and Quality of Life Outcomes 2005, 3:42 http://www.hqlo.com/content/3/1/42
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Strengths of the study include the fact that the validation
was conducted on a large sample of 276 ethnically and
socio-economically diverse women with uUTI in the con-
text of a (non-comparative) clinical trial. The trial was spe-
cifically designed for the validation of the new instrument
and thus incorporated a validated measure (the KHQ) as
well as a clinical evaluation of symptoms.
On unforced principal components factor analysis, one
component explained a high percentage (79%) of the var-
iability in the AIA data. This component was named the
AIA total score and was calculated as the sum of the five
individual AIA items. The total score was found to have
good internal consistency (Cronbach alpha = 0.93). How-
ever, it must be noted that Cronbach alpha scores >0.90
may indicate that items are too similar [20,21].
Mean scores for each AIA item indicated that feeling a lack
of accomplishment and reducing time at work were the
most frequently reported impairments in uUTI; interfer-
ence with social activity was least commonly reported.
The scores were significantly non-Normally distributed
indicating that non-parametric tests should be used in the
analysis of the AIA.
The AIA total score was found to have excellent psycho-
metric properties. Convergent validity was indicated by
high and statistically significant correlations between the
AIA score and related KHQ items and domains. Divergent
validity was indicated by the small and non-significant
correlation between the AIA score and the (unrelated)
KHQ 'personal relationships' domain.
The AIA total score displayed excellent discriminant valid-
ity in relation to clinical evaluation. It discriminated well
between all clinical evaluation groups with the exception
of the 'gross haematuria' evaluation, which might be
expected to be less strongly related to UTI impairment.
The AIA total score was also found to have very high levels
of responsiveness, with strong associations existing
between changes in AIA score and changes in clinical eval-
uation at TOC visit. These associations were all in the
hypothesised direction and were again less associated
with the 'gross haematuria' evaluation.
Conclusion
The AIA questionnaire enables the assessment of the
amount of time an individual's work or regular activities
have been impaired as a result of their UTI. The question-
naire is composed of one domain, a total score, which has
been found to have excellent psychometric properties.
While the measure was designed specifically for use in a
clinical setting, it is likely that it will also be suitable for
use in an epidemiological context and beyond. Further-
more, although the AIA is validated here in the context of
UTI it could also easily be adapted and used to assess
activity impairment in other disease areas.
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